Compare DigitalOcean Holdings Inc (DOCN) vs Revvity Inc (RVTY) Price & Performance

DigitalOcean (DOCN) trades at $129.73, up 4.49% today, showing strong momentum with three consecutive quarterly earnings beats. The stock maintains a bullish technical outlook with support at $124 and resistance at $135. Revenue growth accelerated to 29% year-over-year in Q2 2026, driven by surging AI-native cloud demand, while maintaining robust 40% adjusted EBITDA margins. Analyst consensus remains strongly positive with a $173.71 price target representing 34% upside potential.

DOCN presents compelling growth exposure to the AI infrastructure boom with accelerating revenue and strong profitability, though elevated valuation multiples (P/E 54.94) and high leverage ($1.49B debt) warrant caution. The company's strategic positioning in AI inference workloads and raised 2026 guidance support continued upside, but investors should monitor competitive pressures and execution risks in the rapidly evolving cloud market.

RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.

The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.